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Abstract
An imbalance between pro-survival and pro-death pathways in brain cells can lead to neuronal cell death and
neurodegeneration. While such imbalance is known to be associated with alterations in glutamatergic and Ca
2+ signaling,
the underlying mechanisms remain undefined. We identified the protein Ser/Thr phosphatase protein phosphatase-1 (PP1),
an enzyme associated with glutamate receptors, as a key trigger of survival pathways that can prevent neuronal death and
neurodegeneration in the adult hippocampus. We show that PP1a overexpression in hippocampal neurons limits NMDA
receptor overactivation and Ca
2+ overload during an excitotoxic event, while PP1 inhibition favors Ca
2+ overload and cell
death. The protective effect of PP1 is associated with a selective dephosphorylation on a residue phosphorylated by
CaMKIIa on the NMDA receptor subunit NR2B, which promotes pro-survival pathways and associated transcriptional
programs. These results reveal a novel contributor to the mechanisms of neuroprotection and underscore the importance of
PP1-dependent dephosphorylation in these mechanisms. They provide a new target for the development of potential
therapeutic treatment of neurodegeneration.
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Introduction
N-methyl-D-aspartate receptors (NMDARs) are essential recep-
tors for excitatory neurotransmission and synaptic plasticity in the
nervous system. The activity of these receptors is tightly controlled
by pre-synaptic glutamate release and intracellular protein kinases
and phosphatases through post-translational modifications. Alter-
ations in NMDAR functions and in the balance between
downstream kinases and phosphatases can occur in pathological
conditions, and lead to neuronal excitotoxicity. Excitotoxicity is a
detrimental cellular process that results from excessive glutamate
release, subsequent over-activation of NMDARs and intracellular
calcium (Ca
2+) overload. While high Ca
2+ influx through
NMDARs is generally deleterious and activates signaling pathways
inducing cell death, it can however also be beneficial and stimulate
cell survival pathways leading to neuroprotection [1,2,3]. The
mechanisms that control the recruitment of cell death or cell
survival pathways upon activation of NMDARs are thought to
depend in part, on the Ca
2+ concentration and its route of entry,
but mostly on the subunit composition and localization of the
NMDARs that it activates [4,5]. Several pieces of evidence have
suggested that heteromeric NR1/NR2B receptors are initial
triggers of cell death pathways, while NR1/NR2A receptors
rather lead to cell survival [6]. First, in mature cortical cultures
and in rat in vivo, the activation of NR2B-containing NMDARs
results in excitotoxicity, while the activation of NR2A-containing
NMDARs promotes neuroprotection [6]. Second, NR2B-contain-
ing NMDARs are thought to be localized preferentially at
extrasynaptic sites while NR2A-containing NMDARs are synaptic
[7,8], and activation of extrasynaptic NMDARs and associated
downstream signaling cascades correlates with a pro-death
transcriptional response while activation of synaptic NMDARs
lead to pro-survival transcriptional response [9]. Third, neurotox-
icity induced by glutamate release from astrocytes involves
preferentially extrasynaptic NR2B-containing NMDARs [10,11].
Finally, glutamate sensitivity in neurons increases proportionally to
the level of NR1/NR2B expression [12] as NR2B-containing
NMDARs have a higher affinity for glutamate, slower deactivation
kinetics, and reduced Ca
2+-dependent desensitization when
compared to NR2A-containing receptors [13]. Despite the
multiple evidence supporting a role for NR2B-containing
NMDARs in excitotoxicity however, the major regulators of these
receptors have remained undefined.
Protein phosphorylation is a post-translational modification that
constitutes one of the major modes of regulation of the NMDAR.
Phosphorylation controls the functional properties of NMDARs
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2004, Prybylowski 2004). While several protein kinases are known
to phosphorylate the NMDAR i.e. death-associated protein kinase
1 (DAPK1) [14], Ca
2+/calmodulin (CaM)-dependent protein
kinase II alpha (CaMKIIa) [15], PKA [16], PKC [17] and Src
family kinases [18], it is not entirely clear which protein
phosphatase(s) can induce dephosphorylation. This is an important
limitation because dephosphorylation is as essential as phosphor-
ylation for the control of the receptor’s activity. One of the
potential protein phosphatases that may be involved is protein
phosphatase 1 (PP1). It has several features that make it a likely
candidate for regulating the NMDAR. PP1 is highly abundant in
neurons, and following NMDAR activation, it is recruited to the
receptor and associates with it by binding to specific targeting
partners. There, it decreases NMDAR activity and synaptic
strength by reducing the receptors open probability [19,20].
Further, when activated in hippocampal neurons, for instance
after induction of synaptic plasticity, PP1 can exert neuroprotec-
tive functions, while in contrast, its inhibition exacerbates the
detrimental effect of excitotoxicity [21].
This study examined the contribution of PP1 to the regulation
of the NMDAR in CA1 hippocampal neurons, and its implication
in neuroprotective pathways. We used oxygen-glucose deprivation
(OGD) in organotypic hippocampal cultures to induce NMDAR-
dependent neuronal excitotoxicity [22]. It involves mechanisms
such as membrane depolarization with calcium entry into the cell
and reactive oxygen species (ROS) production. We demonstrate
that PP1a can regulate NR2B-containing NMDARs by dephos-
phorylating a specific residue on NR2B, and that this leads to a
reduction in Ca
2+ overload and an attenuation of excitotoxic
damage. The data shows that PP1a promotes key signaling
cascades downstream of the NMDAR through altered phosphor-
ylation, and can thereby initiate pro-survival programs.
Materials and Methods
Vector construction, virus production and titration
The lentiviral vector pLVPRT-tTRKRAB [23] was used as a
backbone to generate pLVPRT-tTRKRAB-PP1a and pLVPRT-
tTRKRAB-PP1a-EGFP for inducible PP1a expression in neu-
rons. Full-length coding sequence of human (mutated rabbit) PP1a
alone or fused with EGFP (PP1a or PP1a-EGFP) from pEGFP-
C1-PP1a [24] was subcloned between the MluI and SmaI sites of
pLVPRT-tTRKRAB. The constructs were sequenced before virus
production. Recombinant lentiviruses were produced as previously
described [23] using pLVPRT-tTRKRAB-PP1a (PP1a virus),
pLVPRT-tTRKRAB-PP1a-EGFP (PP1a-EGFP virus), a native
pLVPRT-tTRKRAB vector (control virus), a packaging encoding
vector psPAX2 and the envelope encoding vector pMD2G. Viral
particles were titrated using the HIV-1 p24 ELISA test
(PerkinElmer), according to the manufacturer’s protocol.
Slice culture and viral infection
Organotypic hippocampal slices from 5–7 day old postnatal
wild-type C57/BL6 or I-1 transgenic mice were prepared and
cultured for 2 weeks using the roller-tube technique [25]. Slices
prepared from wild-type C57/BL6 mice were transferred to an
empty electrophysiological recording chamber at room tempera-
ture and the CA1 pyramidal cell layer was injected with lentiviral
preparations (,2.10
8 TU/ml, 5–10 injection sites, total volume of
2 ml). Artificial cerebrospinal fluid (aCSF): (in mM) 119 NaCl, 2.5
KCl, 26 NaHCO3, 1.3 NaH2PO4, 1.3 MgCl2, 2.5 CaCl2, and 11
D-glucose, pH 7.4, saturated with 95% O2,5 %C O 2) was used for
control injections. Slices were returned to roller tubes after
injection, and cultured for 1–2 weeks in medium supplemented
with penicillin/streptomycin (1:500; Sigma). One day before
analysis, culture medium was supplemented with 1 mg/ml
doxycycline hyclate (Sigma) to induce PP1a-EGFP, PP1a or I-1
transgene expression. All animal experiments have been approved
by the federal veterinary office (FVO).
Induction of oxygen-glucose deprivation (OGD)
Slices were taken out of the sealed test tubes and washed once in
normal aCSF (see slice culture and viral infection) before OGD
was induced. For this, normal aCSF solution was replaced with an
aCSF solution deprived of oxygen (saturated with 95% N2, 5%
CO2) and glucose (replaced with 11 mM sucrose) and slices were
put back in the incubator for 4 min. Initial conditions were
restored after the 4-min OGD.
Quantitative real-time RT-PCR
For each sample, total RNA from three hippocampal slices was
extracted using the NucleoSpin Kit II (Macherey-Nagel), purified
with Promega’s RQ1 DNase and reverse-transcribed using the
SuperScript First-Strand Synthesis System for RT-PCR II
(Invitrogen). Quantitative PCR was performed using Taqman
probes (Applied Biosystems) and an Applied Biosystem 7500
Thermal Cycler. Each sample was analyzed in triplicate and equal
amount of cDNA was plated. Values were chosen in the linear
range of amplification and comparative Ct method was used to
assess difference in gene expression between samples [26]. b-actin
was used as internal control.
Immunohistochemistry
Slices were fixed overnight at 4uC in 4% paraformaldehyde
(Sigma), 0.1 M phosphate buffer (PB), pH 7.4. Free-floating
sections were washed in 0.1 m PB (361 h), blocked and
permeabilized in 0.1 M PB, 0.4% Triton X-100 (Sigma) and
10% heat-inactivated horse serum (HS; Sigma) for 24 h at 4uC.
Slices were incubated with primary rabbit anti-EGFP (Synaptic
Systems) and anti-NeuN (Chemicon) antibodies (1:1000) for 72 h
at 4uC in 0.1 M PB, 0.4% Triton X-100 and 10% HS. Cultures
were washed in 0.1 M PB 0.4% Triton X-100 (361 h) and
incubated overnight at 4uC with goat anti-rabbit IgG-FITC and
donkey anti-mouse IgG-TRITC fluorescence-conjugated second-
ary antibodies (1:1000; Jackson ImmunoResearch). After washing
in 0.1 M PB, cultures were mounted using Moviol (Molecular
Probes) and stored in the dark at 4uC. Fluorescent images at low
magnification were acquired with a CoolSNAPK4 digital camera
(Roper Scientific) mounted on an Axiophot microscope (Zeiss) and
analysed using MCID Elite 7.0 software (MCID). High magnifi-
cation images were taken with a Zeiss LSM 410 confocal laser-
scanning microscope using excitation wavelengths of 543 nm
(TRITC) and 488 nm (FITC), and images were averaged to
improve signal-to-noise ratio.
Whole-cell recording
Hippocampal slices injected with aCSF, PP1a, PP1a-EGFP or
control virus treated with doxycycline were recorded in whole-cell
configuration. After 15 min of baseline, slices were exposed to
4 min OGD (hypoxic/aglycemic conditions) by switching the
perfusion from normal aCSF (see slice culture and viral infection)
to an aCSF solution deprived of oxygen (saturated with 95% N2,
5% CO2) and glucose (replaced with 11 mM sucrose). After the 4-
min OGD, perfusion with normal aCSF was reinstalled.
Recordings were obtained from CA1 pyramidal neurons at
250 mV. Patch pipettes (4–8 MV) were filled with (in mM)
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(pH 7.2–7.4). Series resistance, typically between 10 and 20 MV,
was regularly monitored and if a change of more than 10%
occurred, cells were excluded. NMDA (100 mM, Sigma) was
pressure ejected (1 bar, 200 ms) at 40 s intervals from a pipette
positioned ,100 mm from the soma of recorded cells. To isolate
the evoked NMDA receptor-mediated currents, the AMPA/
kainate receptor antagonist NBQX 10 mM, the GABAA antagonist
picrotoxin 100 mM (Sigma) and the voltage-gated Na
+ channel
blocker tetrodotoxin 1 mM were added to the bath solution.
Specificity of NMDA receptor currents was verified at the end of
recordings by application of a modified aCSF without Mg
2+ and
containing the non-competitive NMDA receptor antagonist MK-
801 (10 mM). Currents were filtered at 1–2 kHz, stored, and
analyzed off-line. Individual responses to NMDA were measured
from the holding current to the peak and the OGD effect was
expressed relative to the pre-conditioning baseline (mean response
over 5 min prior to OGD and normalized to 100%). Ifenprodil
(3 mM; Tocris Bioscience), NVP-AAM077 (0.1 mM; kindly
provided by Y. Auberson, Novartis, Basel, Switzerland) or KN-
93 (5 mM; Calbiochem) were added to the perfusion 15 min before
recording of the pre-conditioning baseline and maintained
through recording. After 5 min of baseline, slices were exposed
to 4-min OGD (as above). Recordings were made using an
Axopatch 200B amplifier (Axon Instruments), monitored on-line
and analyzed off-line using pCLAMP. Data were pooled across
slices and expressed as mean 6 SEM.
Ca
2+ imaging
CA1 pyramidal cells were filled with the Ca
2+ indicator Oregon
Green 488 BAPTA-1 (20 mM; Invitrogen) via whole-cell recording
patch pipettes (4–8 MV; series resistance 10–20 MV) as previously
described [27]. Cells were clamped at 250 mV as described in the
whole-cell recording section. The indicator was added to the
intracellular solution and excited at 488 nm using a Polychrome I
monochromator from TILL Photonics (Planegg). Fluorescence
images were collected with a cooled CCD camera (Princeton
Instruments) after passing through a FITC emission filter set, and
stored using a software custom-written in the LABVIEW
environment (National Instruments). Time series of 50 images
were collected at 15 sec intervals (exposure time 100 msec) and
analyzed using ImageJ software. The time course of relative
fluorescence changes (DF/F) was analyzed after background
subtraction in regions of interest over the soma as the percentage
ratio (F-F0)/F0, where F0 is the average fluorescence during the
baseline period.
Co-expression of NR2B and TN-XXL calcium indicator
The NR2B mutated construct (NR2B S1303A) was produced
by PCR-based mutagenesis (QuikChange Site-Directed Mutagen-
esis Kit, Stratagene) using full-length NR2B within pRK7-NR2B.
Both pRK7-NR2B (NR2B S1303 WT) and pRK7-NR2B S1303A
(NR2B S1303A) constructs were verified by sequencing. To
achieve NR2B expression and subsequently quantify [Ca
2+]i load
in CA1 pyramidal neurons, organotypic hippocampal cultures
(DIV14-17) were co-transfected with one of the NR2B constructs
(NR2B S1303 WT and S1303A) and the TN-XXL construct
encoding a calcium indicator [28], using Gene Gun (BioRad)
biolistic transfection. Slices transfected with TN-XXL construct
alone were used as control. Successfully transfected cells were
subjected to OGD and analyzed by Ca
2+ imaging.
Propidium iodide labeling
Slice cultures were washed 3 times in culture tubes and
incubated for 4 min with either ACSF (control) or the OGD
solution in an incubator at 3561uC. Cultures were washed 3 times
with ACSF and returned to culture medium containing 2.5 mg/ml
propidium iodide (Sigma) and penicillin/streptomycin (1:500;
Sigma). After 48 h, cultures were photographed with constant
settings using a CoolSNAPK4 camera (Roper Scientific) mounted
on an Axiophot microscope (excitation 546 nm, emission
.590 nm, Zeiss). Images were captured using the same acquisi-
tion parameters and visualized with MCID Elite 7.0 software
(MCID), blind to the treatment group. Images were analyzed
using ImageJ software (NIH) by drawing and positioning a circle of
6000 pixels (diameter of about 0.1 mm) over the brightest region
of CA1 pyramidal layers. The normalized change in average
intensity was calculated by subtracting background fluorescence.
Western blotting
Hippocampal slices were pooled by three and homogenized
using a 26 G needle syringe in 10 mM HEPES, 1 mM MgCl2,
5 mM EDTA, 0.2% (v/v) Triton X-100 (Sigma), 10% (v/v)
glycerol (Sigma), protease inhibitor cocktail (Sigma), phosphatase
inhibitor cocktails 1 and 2 (Sigma), 250 mM PMSF (Sigma), and
15 mM b-mercaptoethanol (Sigma). 20 to 30 mg total protein were
resolved on 8–10% SDS-PAGE and transferred onto a nitrocel-
lulose membrane (BioRad). Membranes were blocked (Rockland
IR blocking buffer, Rockland), and incubated in primary
antibodies (1:1000): rabbit anti-mouse phospho-NMDAR2B Ser
1303 (Upstate), rabbit anti-mouse phospho-NMDAR2B Tyr1472
(Sigma), mouse anti-mouse NMDAR2B (Chemicon), rabbit anti-
mouse phospho-CaMKIIa/b Thr286/287 (Upstate), rabbit anti-
mouse CaMKIIa (Sigma), mouse anti-mouse phospho-CREB
Ser133 (Cell Signaling Technology), rabbit anti-mouse CREB
(Upstate), and mouse anti-mouse b-actin (Sigma). Membranes
were incubated in secondary antibodies (1:10000): goat anti-rabbit
and anti-mouse IRDye 680, goat anti-rabbit and anti-mouse
IRDye 800 (Li-Cor Biosciences). Band intensity was determined
and quantified using an Odyssey IR scanner (Li-Cor Biosciences).
The phospho-protein signal was normalized to the corresponding
protein signal, and b-actin was used as a loading control. Values
from PP1a-expressing and control cultures subjected to OGD
were normalized to values from control cultures where OGD was
not induced.
Co-immunoprecipitation
Protein samples from whole hippocampus lysates were prepared
by homogenization in 500 ml sterile-filtered 50 mM Tris, 120 mM
NaCl, 0.5% NP-40 containing proteinase and phosphatase
inhibitors (1:100; Sigma), followed by centrifugation for 15 min
at 14,000 rpm at 4uC and collection of the supernatant. After 60
to 90 min incubation with 1–2 mg of the corresponding antibody,
20 ml of BSA-precleared pansorbin-protein A beads (Calbiochem)
were added for 45 min at 4uC. The immune complexes were spun
at 8000 rpm for 3 min, washed in high-salt homogenization buffer
(containing 50 mM Tris, 500 mM NaCl and 1% NP-40) and
regular homogenization buffer. Samples were loaded on a 8%
SDS gel and analyzed (see Western blotting). IP antibodies used
were rabbit polyclonal anti-PP1a (Chemicon) and rabbit anti-IgG
(Sigma) as control, and blotting antibodies were rabbit polyclonal
anti-NR2B (Millipore) and mouse monoclonal anti-NR1 C-
terminal (Upstate).
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The GST-NR2B fusion peptide including the NR2B C-terminal
region tail (residues 1221–1501) was expressed in E.Coli from the
pGEX-NR2B vector [29] and purified according to Amersham
Biosciences protocol. In vitro NR2B phosphorylation/dephosphor-
ylation was conducted using purified recombinant CaMKII and
PP1 enzymes (New England Biolabs), according to supplied
protocols. Products were loaded on a 8–10% SDS gel and
phosphorylation was analyzed (see Western blotting).
Statistical analysis
Data are presented as mean normalized to baseline or control 6
SEM. Paired Student’s t-tests were used to compare non-
normalized data. Statistical significance was set at p#0.05(*),
p#0.01(**) and p#0.001(***).
Results
PP1a overexpression in CA1 hippocampal neurons
To address the importance of PP1 in NMDAR-dependent
excitotoxicity in the adult hippocampus, we conditionally
expressed PP1a in CA1 hippocampal neurons using a lentivirus
approach. We chose CA1 neurons because they are highly
vulnerable to excitotoxicity [30]. We generated vectors expressing
PP1a alone (PP1a) or PP1a fused to enhanced green fluorescent
protein (PP1a-EGFP) under the control of the neuron-specific
human prion (hPrion) promoter (Figure 1a). These vectors were
used to overexpress PP1 in organotypic hippocampal slices. In the
slices injected with the PP1a-EGFP vector, EGFP/NeuN co-
staining confirmed the neuronal specificity of PP1a expression,
and showed that expression is homogenous and mainly distributed
across CA1 neurons but is also present in CA3 and dentate gyrus
neurons (Figure 1b). Quantitative real-time RT-PCR showed
that the PP1a vector increased PP1a mRNA expression in the
hippocampus by 36611% (Figure 1c). PP1a protein shows a
somato-dendritic distribution with enrichment in dendritic spines
(Figure S1a and Supporting Methods S1), suggesting its
presence at glutamatergic synapses. In contrast, the other major
catalytic isoform PP1c is enriched in the nucleus (Figure S1b
and Supporting Methods S1).
PP1a overexpression reduces [Ca
2+]i overload and
prevents cell death during excitotoxicity
A critical step in the mechanisms of excitotoxicity is the over-
activation of NMDARs and the resulting overload in intracellular
Ca
2+ ([Ca
2+]i) [31]. Because the functions and properties of the
NMDAR depend on its subunit composition [4,5], it is important
to first determine which receptor subtype contributes to the
increased Ca
2+ influx following excitotoxic insult. We used
oxygen/glucose deprivation (OGD) as paradigm to induce
excitotoxicity in hippocampal neurons and examined the Ca
2+
influx and NMDAR subunit composition by Ca
2+ imaging and
electrophysiological recording. Post-synaptic Ca
2+ influx was made
NMDAR-dependent by blocking alpha-amino-3-hydroxy-5-meth-
yl-4-isoxazolepropionic acid (AMPA) and kainate receptors, c-
aminobutyric acidA (GABAA) receptors, and voltage-gated Na
+
channels, and was visualized by loading individual CA1 pyramidal
neurons with the high-affinity indicator Oregon Green 488
BAPTA-1 (OGB-1). This revealed that somatic [Ca
2+]i was
rapidly and transiently increased during OGD, consistent with
previous reports [32] (Figure 2a,b). Blockade of NR2B-
containing NMDARs with ifenprodil [33] significantly attenuated
this increase, and reduced the overall Ca
2+ load by about 70% (+/
29%), suggesting the contribution of the NR2B subunit. This
effect was specific to NR2B and did not involve NR2A since
blockade of NR2A-containing NMDARs with 0.1 mM NVP-
AAM077 [34] had no effect on [Ca
2+]i. It reduced basal
NMDAR-mediated responses by about 70% (data not shown),
suggesting a efficient inhibition of NR2A responses with little effect
on NR2B [35].
We then assessed whether PP1a contributes to the regulation of
Ca
2+ influx by NR2B-containing NMDARs, using hippocampal
slices in which PP1a was either overexpressed or inhibited. We
found that PP1a overexpression reduces the maximal [Ca
2+]i rise
and Ca
2+ load in hippocampal neurons, and that the reduction
was comparable to that observed with ifenprodil. Conversely,
PP1a inhibition, achieved by transgenic expression of an active
PP1 inhibitor (I-1) [36], (Figure S2a and Supporting
Methods S1), prolonged [Ca
2+]i rise and increased [Ca
2+]i load
(3 7 +/29%) in CA1 neurons subjected to OGD (Figure S2b
and Supporting Methods S1). These results strongly suggest
that PP1a is involved in the bidirectional regulation of Ca
2+ influx
through NMDARs.
Since in excitotoxicity, Ca
2+ overload is often associated with
delayed neuronal death [31], we next examined whether ifenprodil
or PP1a overexpression diminish cellular damage. To visualize cell
death, we used propidium iodide (PI), a marker that rapidly
penetrates cells with damaged membrane and fluoresces upon
binding to DNA. A significant increase in PI staining (2.3 fold+/
20.2) was observed in pyramidal layers in area CA1–CA3 and in
dentate gyrus 48 hours after OGD challenge, indicating massive
neuronal death (Figure 2c,d). Cell death was strongly reduced in
all hippocampal areas including CA1 but also CA3 and dentate
gyrus by both ifenprodil and PP1a overexpression as shown by a
lack of increase in PI staining in these conditions. Neuroprotection
in area CA3 and dentate gyrus likely result from PP1a
overexpression in CA1 region. Indeed, cell death following
excitotoxic insult is known to initially affect CA1 pyramidal cells
in an acute phase followed by delayed damage in area CA3 and
dentate gyrus [30,37]. The protecting effect of PP1 in area CA1
may therefore impact area CA3 and the dentate gyrus after a
delay. Together, these findings strongly suggest that [Ca
2+]i
overload during OGD is largely mediated by NR2B-containing
NMDARs, and that such overload and the resulting cellular
damage can be prevented by PP1a.
NR2B Ser1303 phosphorylation contributes to [Ca
2+]i
overload and is prevented by PP1a overexpression or
CaMKII inhibition
Changes in intracellular [Ca
2+]i are known to modulate Ca
2+-
dependent signaling pathways and alter the activity of Ca
2+-
activated enzymes, in particular Ca
2+/calmodulin-dependent
protein kinase II (CaMKII). CaMKII is a serine/threonine protein
kinase that can autophosphorylate on several residues in the
presence of Ca
2+ [38]. Autophosphorylation on Thr286 confers
autonomous Ca
2+-independent activity to the enzyme [38,39,40],
and promotes its association with the PSD [41]. We examined
whether CaMKII Thr286 phosphorylation is modulated by OGD
in our experimental conditions, and whether PP1a influences this
autophosphorylation. Western blot analyses revealed that Thr286
phosphorylation was significantly increased 1 min after OGD (1.4
fold+/20.1), a time point that corresponds to maximum [Ca
2+]i
peak, then returned to baseline within 16 min in control slices
(Figure 3a). This effect was specific to CaMKIIa phosphorylation
and was not accompanied with any change in the total level of the
protein. Since in the PSD, CaMKIIa can be dephosphorylated by
PP1 [41], we also investigated the effect of PP1a overexpression on
Thr286 phosphorylation. We observed that CaMKII Thr286
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1 min after OGD (Figure 3a). PP1a overexpression did not
induce any change in CaMKII Thr286 phosphorylation.
Since the toxic [Ca
2+]i overload during OGD is largely
mediated by NR2B-containing NMDARs (Figure 2a,b), and
correlates with CaMKIIa activation by Thr286 phosphorylation,
we next examined the link between CaMKIIa and NR2B-
containing NMDARs. We determined whether Ser1303 on
NR2B, a site phosphorylated by CaMKIIa [15], is modulated
by OGD. Western blot analyses showed that Ser1303 phosphor-
ylation was significantly increased 1 min after OGD (3.8 fold+/
20.9) and returned to baseline within 16 min in control slices,
without any change in the total level of NR2B (Figure 3b).
Similar to CaMKII phosphorylation, this increase correlated with
the maximum [Ca
2+]i peak, suggesting a link between NR2B
Ser1303 phosphorylation, CaMKII phosphorylation and Ca
2+
entry. Consistently, we observed that the increase in NR2B
phosphorylation was abolished by KN-93, a specific CaMKII
inhibitor (Figure 3b). Furthermore, PP1a expression significantly
reduced the level of phosphorylated NR2B Ser1303 1 min after
OGD (Figure 3b), while no effect was observed in non-OGD
conditions.
To confirm the specific effect of NR2B Ser1303 phosphoryla-
tion on Ca
2+ overload, we next tested whether a loss of this residue
abolishes such overload. We co-expressed a native (NR2B S1303
WT) or mutated NR2B subunit carrying a Ser1303 to Ala1303
substitution (NR2B S1303A) that prevents phosphorylation, with a
highly sensitive Ca
2+ indicator [28] (TN-XXL) using biolistic
transfection in organotypic hippocampal slices. The analysis of
isolated post-synaptic NMDAR-dependent Ca
2+ influx in CA1
pyramidal neurons expressing native NR2B revealed a rapid and
transient two-fold increase in somatic [Ca
2+]i during OGD
(Figure 4a, b). This increase was prevented by blockade of
NR2B Ser1303 phosphorylation in slices expressing NR2B
S1303A. The effect of NR2B S1303A expression was not resulting
from incorrect trafficking to the surface as observed in transfected
Neuro-2a cells (Figure S3 and Supporting Methods S1).
Moreover, there was no significant difference in TN-XXL
expression when comparing cells transfected with the different
NR2B variants (Figure S4 and Supporting Methods S1).
These data overall strongly suggest that Ser1303 phosphorylation
is required for OGD-induced Ca
2+ overload.
Following the demonstration that OGD-induced Ca
2+ overload
and the resulting cellular damage are prevented by PP1a
(Figure 2), we next hypothesized that PP1a mediates its
Figure 1. Inducible and neuron-specific PP1a expression in hippocampus. (a) Schematic representation of the genetic system used to
achieve doxycycline-dependent and neuron-specific PP1a or PP1a-EGFP expression in mouse organotypic hippocampal slices. Upon doxycycline
treatment, binding of the tetracycline repressor and Kru ¨ppel-associated box fusion protein (tTR-KRAB) to the tetracycline response element (tetO) is
blocked, which prevents the epigenetic silencing of the human prion (hPrion) promoter and allows PP1a or PP1a-EGFP expression. (b) EGFP (green)
and NeuN (red) co-immunostaining in CA1 area showing neuron-specific PP1a-EGFP expression. Scale bar, 400 mm in A–C, 200 mm in D–F, and 25 mm
in G–I. (c) Real-time quantitative RT-PCR showing increased PP1a mRNA expression in slices injected with PP1a (n=14) compared to control slices
(n=8). Data is expressed as relative quantification. *p,0.05. Error bars represent mean SEM.
doi:10.1371/journal.pone.0034047.g001
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hypothesis, we determined whether PP1a associates with NR2B,
and whether this correlates with NR2B dephosphorylation. Co-
immunoprecipitation assays in mouse hippocampal extracts using
anti-PP1a, anti-NR2B or -NR1 antibodies revealed that PP1a
does interact with NR2B and NR1 subunits (Figure 4c). These
results are in agreement with a previous report showing that PP1
forms a complex with the NMDAR [16]. Further, in the presence
of a purified NR2B fragment (aa 1221–1482) phosphorylated by
CaMKII, PP1a was able to fully dephosphorylate Ser1303 within
30 min in vitro (Figure 4d). These results provide further evidence
for a direct effect of PP1a on NR2B Ser1303 [42].
NR2B Ser1303 phosphorylation alters NMDAR functions
and CREB-dependent gene expression
NR2B Ser1303 phosphorylation is associated with increased
[Ca
2+]i, and Ca
2+ is known to modulate NMDAR activity.
Therefore, we examined whether NMDAR currents are altered by
OGD. Isolated post-synaptic NMDAR currents were induced by
pressure application of NMDA onto CA1 neurons and recorded in
voltage clamp whole-cell configuration. In control slices, NMDAR
currents progressively increased during the 4-min OGD and
reached a plateau at about 168% of baseline, 2 min after the end
of OGD (Figure 5a, b). This increase was stable (over 25 min),
indicating a persistent potentiation of NMDAR currents by OGD,
consistent with previous reports [37]. While NVP-AAM077 had
Figure 2. Blockade of Ca
2+ rise and delayed cell death induced by OGD by ifenprodil and PP1a in CA1 pyramidal cells. (a) OGD-
induced increase in DF/F (% relative to basal level) in control and NVP-AAM077-treated slices (control, n=7; NVP-AAM077, n=7). This increase is
prevented by ifenprodil perfusion (n=8) or by PP1a expression (n=7). Schematic representation of a hippocampal slice showing the patch-clamp
electrode filled with OGB-1 (left inset). Image of a CA1 pyramidal neuron loaded with OGB-1 with outlined region of interest (cell soma) used to
calculate fluorescence (middle inset). Relative fluorescence (DF/F) traces of individually recorded CA1 pyramidal neurons in control slices, PP1a
expressing slices, and slices treated with NVP-AAM077 or ifenprodil subjected to OGD (right inset). (b) Quantitative histogram illustrating the area
under the curve used as a measure of intracellular Ca
2+ overload during 4 min OGD, given by the calculation of DF/F integral normalized to control.
*p,0.05. (c) Propidium iodide labeling of hippocampal slices showing massive cell death in the CA1 pyramidal cell layer (red staining) 48 h after OGD
(control OGD, n=7). Ifenprodil treatment (n=6) and PP1a expression (n=5) significantly reduced cell death as shown by an almost absent PI labeling
after OGD. No cell death was observed in slices maintained in ACSF (control ACSF, n=8; ifenprodil ACSF, n=8; PP1a ACSF, n=7). Scale bar: 400 mm.
(d) Quantitative histogram with normalized labeling intensity. ***p,0.001.
doi:10.1371/journal.pone.0034047.g002
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abolished this potentiation and induced a full recovery of
NMDAR currents a few minutes after OGD (Figure 5a, b).
These results confirm that NR2B underlies the prolonged
potentiation of NMDAR currents induced by excitotoxicity.
Our previous work has shown that PP1 influences the recovery
of fEPSPs from OGD in hippocampus. Its inhibition by specific
inhibitors or after induction of long-term potentiation (LTP)
prevents fEPSPs recovery while, in contrast, its activation by
induction of long-term depression (LTD) restores fEPSPs [21].
Since PP1 contributes to the regulation of NMDARs [19] and
blocks excitotoxic [Ca
2+]i overload, we next examined whether it
has a positive effect on fEPSPs recovery and NMDAR currents
after OGD. When PP1a was expressed in hippocampal slices, the
transient decrease in fEPSPs and increase in NMDAR currents
induced by OGD were abolished, and both fEPSPs and NMDAR
currents fully recovered (Figure 5a,b, Figure S5 and
Supporting Methods S1). Further, consistent with the implica-
tion of CaMKII in [Ca
2+]i overload, CaMKII inhibition by KN-
93 prior to OGD significantly reduced the potentiation of
NMDARs currents, and led to a full recovery of these currents
(Figure 5a,b).
Since protein tyrosine kinases of the Src family are involved in
the regulation of NMDAR functions [43] and are associated with
excitotoxicity [44,45], we also investigated Tyr phosphorylation of
NR2B. We examined Tyr1472, a residue phosphorylated by Src
kinases and associated with NMDAR stabilization at the
membrane [46]. Tyr1472 phosphorylation was increased by 1.5
fold (+/20.3) 1 min after OGD and by 1.9 fold (+/20.5) after
16 min (Figure S6a). This increase was prevented by the tyrosine
kinase inhibitor PP2 and by CaMKII inhibition with KN-93,
while no effect was observed in non-OGD conditions. These
results confirm the involvement of Tyr phosphorylation of NR2B
in OGD and suggest a potential link between Tyr and Ser/Thr
phosphorylation pathways.
Finally, since excitotoxicity is associated with disruption of
cAMP response element-binding protein (CREB)-dependent
pathways in CA1 neurons [47,48], we examined whether CREB
phosphorylation on Ser133 and CREB-dependent gene expression
are altered by OGD. On Western blots, we observed that CREB
phosphorylation on Ser133 was significantly decreased 1 min after
OGD (by 0.47 fold+/20.09) and returned to baseline within
16 min (Figure S6b). This decrease was prevented by CaMKII
inhibition with KN-93, consistent with the fact that it occurred at
the same time point (1 minute after OGD) as CaMKII-mediated
NR2B phosphorylation and [Ca
2+]i overload. Further, it was
accompanied by reduced expression of the CREB target genes,
pro-survival marker B-cell lymphoma 2 (Bcl-2) and the immediate
early gene c-fos [49], about 20 minutes after OGD (0.86 fold+/
20.02 and 0.76 fold+/20.07). Importantly, this reduction was
fully reversed by PP1a overexpression, confirming the critical role
of PP1a in the reversal of the effects of excitotoxicity (Figure S6c).
Figure 3. PP1a reverses CaMKIIa Thr286 phosphorylation and mediates the dephosphorylation of NR2B Ser1303 upon OGD. (a)
Representative Western blots and corresponding quantitative analysis of CaMKIIa Thr286 phosphorylation. CaMKIIa phosphorylation significantly
increases 1 min after OGD (control 1 min post-OGD, n=8) with no significant change at 16 min (control 16 min post-OGD, n=6) in control slices.
PP1a slices do not display any change in CaMKIIa phosphorylation either 1 min (PP1a 1 min post-OGD, n=6) or 16 min post-OGD (PP1a 16 min post-
OGD, n=7) compared to control. Phospho-protein levels were normalized to non-phosphorylated protein levels and b-actin was used as a loading
control. Quantitative data for each condition were normalized to levels of non-OGD condition (control non-OGD, n=14) from the same blot and
exposure. *p,0.05. (b) Representative Western blots and corresponding quantitative analysis of NR2B Ser1303 phosphorylation. Increased level of
phospho-NR2B in control slices 1 min after OGD (control 1 min post-OGD, n=9), but not 16 min after OGD (control 16 min post-OGD, n=8). PP1a
expression or KN-93 treatment blocks this increase (PP1a 1 min post-OGD, n=6; KN-93 1 min post-OGD, n=6), but has no effect 16 min post-OGD
(PP1a 16 min post-OGD, n=8; KN-93 16 min post-OGD, n=5). Phospho-protein levels were normalized to non-phosphorylated protein levels, and b-
actin was used as a loading control. Quantitative data for each condition were normalized to levels of non-OGD condition (control non-OGD, n=14)
from the same blot and exposure. *p,0.05.
doi:10.1371/journal.pone.0034047.g003
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This study identifies a novel mechanism for the control of the
switch between cell death and cell survival pathways in
hippocampal neurons that involves NR2B-containing NMDARs
and the protein phosphatase PP1a. The data demonstrate that the
selective phosphorylation of NR2B on Ser1303 by CaMKII is an
initial trigger for intraneuronal Ca
2+ overload during excitotoxicity
and that dephosphorylation of this residue by PP1a confers
neuroprotection. They further show that the effect of PP1a is
mediated by a normalization of NMDAR currents followed by a
decrease in Ca
2+ overload, a restoration of CREB-dependent gene
expression, and prevention of delayed neuronal cell death.
These findings are of primary importance for the understanding
of the mechanisms of regulation of the NMDAR in adult
hippocampal neurons because they newly reveal how the Ser/
Thr protein phosphatase PP1a regulates NMDAR functions by
acting on a single residue (Ser1303) located on NR2B. Protein
phosphorylation is recognized to be a critical regulation mecha-
nism of NMDAR functions, but the residues and enzymes
involved in the adult hippocampus have to date only been
partially identified. This is particularly true for Ser/Thr
phosphorylation, which is known to occur on Ser1303 and 1323
on NR2B and to involve DAPK1, CaMKII, and PKC [14,15,17].
However, the reversal of phosphorylation by protein phosphatases
remains unclear. The identification of PP1a as a specific
phosphatase of Ser1303 on NR2B provides new insight onto the
modes of regulation of the NMDAR in hippocampal neurons
[20,50]. It will be of interest in the future to assess the mechanisms
by which Ser1303 phosphorylation/dephosphorylation modulates
NMDAR functions, this might involve conformational changes
[5], a change in NMDAR channel open probability [19], and/or
reduced coupling with downstream signaling pathways.
The fact that PP1a co-localizes with NR2B and acts directly on
this subunit suggests that it is strategically positioned at the
NMDAR to initiate downstream signaling. There, it appears to
negatively modulate pathways regulating intracellular Ca
2+
homeostasis, and Ca
2+-dependent enzymes such as CaMKIIa.
The mechanisms recruited to limit Ca
2+ entry are not known but
may involve L-type voltage-gated Ca
2+ channels [51], Ca
2+-
permeable AMPA receptors [52,53], and/or acid-sensing ion
channels [54], which may be overactivated by CaMKIIa-
mediated phosphorylation. PP1a may also favor neuroprotective
signaling cascades involving group I metabotropic glutamate
receptors a (mGluR1a), PI3 kinase or Akt, and/or perhaps limits
mGluR1a-dependent Ca
2+ release from intracellular stores that
participate to excitotoxic Ca
2+ overload [55].
Signaling cascades downstream of NMDARs also contribute to
pro-apoptotic programs in ischemic conditions. Activation of
NR2B-containing NMDARs by CaMKIIa triggers a Ca
2+
Figure 4. NR2B Ser1303 phosphorylation is necessary and sufficient to drive Ca
2+ overload. (a) Expression of wild-type NR2B (NR2B
S1303 WT, n=6) increased OGD-induced DF/F (% relative to basal level), while expression of NR2B mutated on Ser1303 (NR2B S1303A, n=5) was not
changed compared to control slices (control, n=6). C-terminus amino-acid sequence of NR2B S1303 WT and NR2B S1303A mutated version with
substitution of serine with alanine on residue 1303 in shaded grey (left inset). Relative fluorescence (DF/F) traces of individually recorded CA1
pyramidal neurons in control, NR2B S1303A, and NR2B S1303 WT slices subjected to OGD (middle inset). Image of a CA1 pyramidal neuron expressing
the calcium sensitive dye TN-XXL with outlined region of interest (cell soma) used to assess fluorescence and [Ca
2+]i (right inset). (b) Quantitative
histogram illustrating the area under the curve used as a measure of total intracellular Ca
2+ load, given by the calculation of DF/F integral normalized
to control. *p,0.05. (c) Representative Western blot showing co-immunoprecipitation of NR2B and NR1 with PP1a using a PP1a antibody in mouse
hippocampus lysates. No protein interaction was observed with non-specific IgG. PP1a and IgG immunoprecipitation was performed using a
comparable amount of antibodies, and samples were loaded on the same blot (same exposure). (d) PP1 directly dephosphorylates Ser1303 in vitro.
Immunoblot analyses showing the time course of PP1-mediated dephosphorylation on Ser1303 from a GST-fused NR2B C-terminal peptide. GST-
NR2B (aa 1221–1482) was incubated with active PP1 following Ser1303 phosphorylation by CaMKII. NR2B was used as loading control.
doi:10.1371/journal.pone.0034047.g004
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delayed cell death. This at the same time also lowers PP1 activity
[21]. Consistently, we demonstrate that increased PP1a activity
counteracts the Ca
2+ overload similarly to CaMKIIa inhibition
and NR2B-containing NMDAR blockade. Further, the inhibition
of PP1 prolongs Ca
2+ influx, suggesting that endogenous PP1 can
restore a normal concentration of intracellular Ca
2+ upon
excitotoxic insult. In vivo, the mechanisms leading to PP1 activation
or inhibition in the hippocampus are not fully understood but may
involve inhibitory targeting partners or inhibitors such as
inhibitor-1 [56].
The contribution of NMDARs to excitotoxicity contrasts with
the positive role of the receptor in normal excitatory neurotrans-
mission, synaptic plasticity, and memory processes [57]. Such dual
functions may be mediated by different populations of NMDARs
coupled to distinct interacting partners and/or signaling cascades.
NMDAR-dependent pro-death signaling involves NR2B coupling
to the stress-activated protein kinase p38 in neurons [58].
Blockade of NR2B and p38 interaction reduces excitotoxic
neuronal death without affecting NMDAR-mediated Ca
2+ influx
and synaptic plasticity, suggesting a specific role of NR2B-
containing NMDAR downstream signaling in neuronal death.
For some forms of synaptic plasticity such as LTP, NR2B-
containing NMDARs associate with CaMKII following the
recruitment of the kinase to the receptor [59]. In contrast,
synaptic depression such as LTD induces the recruitment of PP1
to NMDARs [20,21], most likely to extrasynaptic NR2B-
containing NMDARs which are negatively regulated during
LTD in the hippocampus [60]. Together with these findings, the
present data suggest that PP1 may promote LTD by lowering
NR2B-containing NMDAR activity, and operate extrasynaptically
[61]. Finally, these findings strengthen previous reports showing
that signaling through extrasynaptic NMDARs promotes cell
death [48], and provide novel perspectives for its blockade by PP1.
They underscore the potential of pharmacological approaches
targeting protein phosphatases rather than approaches based on
NMDAR antagonists, which have severe side effects [62], for the
treatment of excitotoxicity in pathologies such as ischemic stroke.
These data together with a previous report showing that PP1
inhibition improves memory in aged mice [36] support the
therapeutic potential of PP1 modulation in brain disorders and
aging.
Supporting Information
Figure S1 Somato-dendritic distribution of PP1a in hippocam-
pal neurons. (a) Cultured hippocampal neurons (DIV11) were
transfected with the PP1a-EGFP construct, and fixed 4 days later.
Confocal laser microscopy images of a hippocampal pyramidal
neuron expressing EGFP-tagged PP1a (green fluorescence, A–C).
PP1a is enriched at dendritic spines, as shown at higher
magnification (B, C). Scale bar represents 40 mmi nA ,2 0mmi n
B, and 10 mmi nC .( b) PP1a (PP1a-EGFP) and PP1c (PP1c-
EGFP) subcellular localization. PP1a is excluded from the nucleus,
whereas PP1c is enriched in the nucleus. Scale bar: 30 mm.
(TIF)
Figure S2 PP1 inhibition increases OGD-mediated Ca
2+
overload. (a) I-1 expression in organotypic hippocampal cultures.
I-1 transgene mRNA is detected in slices prepared from I-1
transgenic mice and treated with doxycycline (I-1). No I-1
expression in I-1 slices not treated with doxycycline (I-1 no dox)
or in doxycycline-treated wild-type slices (WT). –RT (no reverse
transcription) and H2O as PCR negative controls. (b) I-1
Figure 5. PP1a expression and CaMIIa inhibition normalize NR2B-containing NMDAR-mediated currents after excitotoxicity. (a)
Significant enhancement of NMDAR currents following 4 min OGD in control slices (control, n=6). Expression of PP1a (n=5), ifenprodil treatment
(n=8), and KN-93 treatment (n=6) led to a full recovery of NMDAR currents 6 min after the end of OGD. NVP-AAM077 (n=5) has no effect on
NMDAR currents that remain potentiated throughout recording. Top left, Schematic representation of an organotypic hippocampal slice showing the
positioning of the recording patch-clamp electrode and the puffing pipette. Top right, Individual responses from single CA1 pyramidal neurons
before (1), during (2) and 10 min after (3) OGD. (b) Time course of OGD mean effect on NMDAR currents.
+++p,0.001, ***p,0.001.
doi:10.1371/journal.pone.0034047.g005
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2+ influx (left panel) and increases overall
[Ca
2+]i load (right panel) upon OGD as seen by DF/F ratio (%
relative to basal level) and normalized DF/F integral in control
and I-1 slices (control, n=7; I-1, n=5). *p,0.05.
(TIF)
Figure S3 The NR2B S1303 mutant subunit is properly
expressed and addressed to the membrane. Cultured Neuro-2a
cells were co-transfected with expression vectors for the NR1
subunit and for N-terminally green fluorescent protein-tagged
mutated NR2B at Ser1303 (GFP-NR2B S1303A) or GFP-tagged
wild-type NR2B (GFP-NR2B WT) subunit. Cells were fixed 4 days
later and incubated with GFP and NR2B antibodies without
permeabilization. Fluorescent secondary antibodies were applied
and cells were imaged with a fluorescent microscope. Surface GFP
(green) and NR2B (red) staining was simultaneously observed in
NR1/GFP-NR2B S1303A and NR1/GFP-NR2B WT transfected
neuro-2a cells. Scale bar: 30 mm.
(TIF)
Figure S4 Co-expression of the Ca
2+ indicator TN-XXL and a
native (NR2B S1303 WT) or a mutated NR2B subunit (NR2B
S1303A) upon biolistic transfection in organotypic hippocampal
slices. (a) Image of a CA1 neuron expressing TN-XXL as shown
by green fluorescence. Neuronal layers of the hippocampus are
visualized by NeuN staining (red). (b) High magnification images
of TN-XXL fluorescence in NR2B S1303 WT (top panel) and
NR2B S1303A expressing neurons (bottom panel).
(TIF)
Figure S5 Effect of transient OGD on field extracellular post-
synaptic potentials (f-EPSP) slope in area CA1 of organotypic
hippocampal slices injected with a control virus (control), a PP1a-
expressing virus (PP1a) or not injected (non-injected). Quantitative
histogram (right panel) of mean f-EPSP slope (over the last 20 min
of recording) showing a significant increase in f-EPSP slope
recovery in slices overexpressing PP1a (n=6) compared to control
(n=7) or non-injected slices (n=9). ***p,0.001. Schematic
representation of an organotypic hippocampal slice with the
stimulating electrode positioned on Schaffer collateral fibers and
the recording electrode within the stratum radiatum (left inset).
Individual responses from single slices before (1), during (2) and
10 min after (3) OGD (right inset).
(TIF)
Figure S6 NR2B Ser1303 phosphorylation initiates cell death
pathways upon OGD. (a) Representative Western blots and
corresponding quantitative analysis of NR2B Tyr1472 phosphor-
ylation. Increased level of phospho-NR2B in control slices 1 min
after OGD (control 1 min post-OGD, n=6), and 16 min after
OGD (control 16 min post-OGD, n=5). KN-93 and PP2
treatments block these increases both 1 min post-OGD (KN-93
1 min post-OGD, n=5; PP2 1 min post-OGD, n=6) and 16 min
post-OGD (KN-93 16 min post-OGD, n=6; PP2 16 min post-
OGD, n=6). Phospho-protein levels were normalized to non-
phosphorylated protein levels and b-actin was used as a loading
control. Quantitative data for each condition were normalized to
levels of non-OGD condition (control non-OGD, n=7) from the
same blot and exposure. *p,0.05, **p,0.01. (b) Representative
Western blots and corresponding quantitative analysis of CREB
Ser133 phosphorylation. CREB phosphorylation was significantly
decreased 1 min after OGD (control 1 min post-OGD, n=8) with
no significant change at 16 min (control 16 min post-OGD, n=7)
in control slices. PP1a expression avoids phospho-CREB depletion
1 min post-OGD. Phospho-protein levels were normalized to non-
phosphorylated protein levels and b-actin was used as a loading
control. Quantitative data for each condition were normalized to
levels of non-OGD condition (control non-OGD, n=8) from the
same blot and exposure. *p,0.05. (c) Quantitative RT-PCR data
showing a significant reduction in Bcl-2 mRNA level and
decreased c-fos mRNA level in control slices subjected to OGD
(Bcl-2, n=9; c-fos, n=8) compared to non-OGD slices (Bcl-2,
n=12; c-fos, n=3). PP1a significantly up-regulates Bcl-2
expression (n=9) and increases c-fos mRNA level (n=9). Data
are expressed as relative quantification. *p,0.05.
(TIF)
Methods S1 Methods for data presented in Supporting Figures:
Neuronal culture transfection, I1 RT-PCR, Neuro-2a cell
transfection and immunocytochemistry, Field recording.
(DOC)
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